2024-515343-39-00已完成2 期
Phase II multicenter randomized trial evaluating the association of PIPAC and systemic chemotherapy versus systemic chemotherapy alone as 1st-line treatment of Malignant Peritoneal Mesothelioma - MESOTIP
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 66
- 试验地点
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Dr Olivia SGARBURA
Scientific
Institut Regional Du Cancer De Montpellier
研究点 (10)
Loading locations...
相似试验
招募中
2 期
A multicenter phase II randomized trial to evaluate systemic therapy versus systemic therapy in combination with stereotactic radiotherapy in patients with metastatic colorectal cancerBowel cancerrectum cancer1001799010017991colon cancerNL-OMON52282niversitair Medisch Centrum Utrecht105
招募中
2 期
A multicenter randomized phase II trial evaluating the efficacy and safety of intrapericardial left superior pulmonary vein ligation or division for prevention of thrombosis in the stumpmalignant tumor of the lungJPRN-UMIN000036037iigata Chest Surgery Study Group60
进行中（未招募）
不适用
A multicenter randomized phase II Trial assessing the activity of Gemcitabine - Oxaliplatin chemotherapy alone or in combination with Cetuximab in patients with advanced biliary cancer - BINGOadenocarcinoma of the biliary tract ( gallbladder, intra and/ or extrahepatic bile ducts, ampulla of Vater)EUCTR2007-001200-20-DEMedizinische Hochschule Hannover100
已完成
2 期
A multicenter randomized phase II clinical trial with neo -adjuvant chemotherapy containing eribulin mesylate for triple negative primary breast cancer patients (Neo-Entrance study)Patients with operable primary triple-negative breast cancer without prior treatmentJPRN-UMIN000023162Japan Breast Cancer Research Group)100
进行中（未招募）
1 期
Encorafenib and binimetinib before local treatment in patients with BRAF mutated melanoma with metastasis to the brain.EUCTR2018-002530-20-ESGrupo Español Multidisciplinar de Melanoma63